What is the safest and easiest medication regimen for rapid‑sequence intubation in a typical adult patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Safest and Easiest RSI Medication Regimen

For the typical adult patient, use ketamine 1–2 mg/kg IV followed immediately by rocuronium 1.0–1.2 mg/kg IV, as this combination provides excellent intubating conditions with maintained hemodynamic stability and avoids the adrenal suppression concerns associated with etomidate. 1

Primary Medication Regimen

Induction Agent: Ketamine

  • Administer ketamine 1–2 mg/kg IV as your first-line induction agent, using the lower end of the dosing range (1 mg/kg) in patients with cardiovascular compromise 1, 2
  • Ketamine maintains hemodynamic stability through sympathomimetic properties that preserve blood pressure via endogenous catecholamine release, making it particularly advantageous in the undifferentiated patient 2
  • The 2023 Society of Critical Care Medicine guidelines found no mortality difference between ketamine and etomidate in critically ill patients (OR 0.95; 95% CI 0.72–1.25) 3

Neuromuscular Blocking Agent: Rocuronium

  • Administer rocuronium 1.0–1.2 mg/kg IV immediately after ketamine to ensure optimal intubating conditions 1, 4
  • Rocuronium at this dose provides excellent intubating conditions within 60–90 seconds, comparable to succinylcholine 4, 5
  • Wait at least 60 seconds after rocuronium administration before attempting intubation 1

Critical Post-Intubation Protocol

Immediate Analgosedation (Most Important Safety Step)

  • Implement protocolized post-intubation analgosedation immediately after successful intubation to prevent awareness during the 30–60 minute duration of rocuronium-induced paralysis, which far outlasts ketamine's dissociative effects 1
  • The incidence of explicit recall during emergency intubation is approximately 2.6%, and this risk is substantially reduced when immediate post-intubation sedation protocols are followed 1, 2
  • Assign a dedicated team member (ideally a clinical pharmacist) to manage post-intubation analgosedation timing 1
  • The median time to first analgosedative intervention should be approximately 7 minutes (IQR 3–13 minutes) 6

Alternative Regimen: Etomidate-Based

When to Consider Etomidate

  • Etomidate 0.2–0.3 mg/kg IV remains an acceptable alternative in hemodynamically unstable patients, though it offers no mortality advantage over ketamine 1, 2
  • Use the lower dose (0.15–0.2 mg/kg) in patients with hemodynamic compromise 1
  • Critical dosing caveat: Do not exceed 0.3 mg/kg in patients over 55 years, as higher doses are associated with oxygen desaturation requiring bag-valve-mask ventilation 1

Etomidate Considerations

  • Despite causing transient adrenal suppression, corticosteroid administration following etomidate is NOT recommended, as multiple RCTs showed no mortality benefit 1
  • Etomidate may cause pain on injection, myoclonic movements, hiccups, nausea, and vomiting 7

Alternative Neuromuscular Blocker: Succinylcholine

When to Use Succinylcholine

  • Succinylcholine 1–1.5 mg/kg IV is an alternative when rocuronium is unavailable or when shorter duration of paralysis (5–10 minutes) is desired 1
  • Onset is 30–45 seconds, slightly faster than rocuronium 1
  • The shorter duration eliminates the awareness risk window that exists with rocuronium 1

Succinylcholine Contraindications

  • Contraindicated in patients with history of malignant hyperthermia, severe burns or crush injury, spinal cord injury, or risk of hyperkalemia 1

Essential Safety Measures

Hemodynamic Preparation

  • Have vasopressors immediately available during RSI with any induction agent, as post-intubation hypotension is common and associated with increased mortality 2, 3
  • In critically ill patients with depleted catecholamine stores (prolonged septic shock, severe cardiogenic shock), ketamine may paradoxically cause hypotension despite its sympathomimetic properties 1, 3

Dosing by Body Weight

  • Dose all RSI medications based on actual body weight, not ideal body weight, as this is critical for optimal intubating conditions 1, 4
  • Obese patients dosed by ideal body weight had longer time to maximum block and shorter clinical duration 4

Preoxygenation

  • Position the patient in semi-Fowler position (head and trunk inclined) during RSI to improve first-pass success 1
  • Use high-flow nasal oxygen when challenging laryngoscopy is anticipated 1

Special Population Considerations

Head-Injured Patients

  • Ketamine is safe and appropriate for RSI in head-injured patients when used with controlled mechanical ventilation 3
  • Historical concerns about ketamine increasing intracranial pressure have been refuted by evidence from 2009–2013 3

Septic Patients

  • Strongly prefer ketamine over etomidate in septic patients, particularly in pediatric populations where guidelines explicitly recommend against etomidate 1

Obstetric Patients

  • Rocuronium is NOT recommended for rapid sequence induction in Cesarean section patients due to inadequate intubating conditions when attempted at 60 seconds with lower thiopental doses 4

Common Pitfalls to Avoid

  • Never administer the neuromuscular blocker before the induction agent, as this causes awareness during paralysis 1
  • Never forget post-intubation analgosedation when using rocuronium, as the 30–60 minute paralysis duration far exceeds ketamine's sedative effects 1
  • Never use propofol in hemodynamically unstable patients, as it has the most profound effect on blood pressure among induction agents 2
  • Never dose obese patients by ideal body weight, as this results in inadequate intubating conditions 1, 4

References

Guideline

Rapid Sequence Intubation Medication Regimen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ketamine vs Etomidate for RSI in Trauma Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Ketamine for Rapid Sequence Intubation in Head Injury Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the step-by-step medication guide for inducing Rapid Sequence Intubation (RSI), including first-line dosages and indications for alternative dosing?
What are the best induction and paralytic agents for Rapid Sequence Intubation (RSI) in patients with acute decompensated heart failure?
What is the agent used for rapid sequence intubation (RSI)?
What are the nursing care interventions for Respiratory Syncytial Virus (RSV) infection?
What medications should be given before performing rapid sequence intubation (RSI) on an adult patient?
What are the possible causes of bilateral hearing loss in a 40-year-old woman?
For a patient with refractory gastroesophageal reflux disease on omeprazole 40 mg twice daily who is also taking budesonide/formoterol (Symbicort), tiotropium, montelukast, and olopatadine/mometasone (Ryaltris), which proton‑pump inhibitor—omeprazole or esomeprazole—is preferable?
I have purpura on my feet after surgery; what could be causing it and how should I evaluate and manage it?
What are the recommended starting doses and titration schedules for carvedilol in chronic heart failure (NYHA class II‑IV), hypertension, and post‑myocardial infarction left‑ventricular dysfunction, including dose adjustments for elderly patients and hepatic impairment?
In a typical adult without contraindications, can hepatitis A vaccine be given one week after an erroneous Engerix B (hepatitis B) dose that was given instead of the second dose of Twinrix (combined hepatitis A and B vaccine)?
What is a sample intravenous amiodarone dosing calculation for a 70‑kg adult with a ventricular arrhythmia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.